Independent Director · TENAX THERAPEUTICS, INC. (TENX)

Declan Doogan — TENAX THERAPEUTICS Director Compensation (2025)

Fiscal year 2025 director compensation for Declan Doogan at TENAX THERAPEUTICS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 22, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

TENAX THERAPEUTICS Director Compensation Table · the one fiscal year held
In US dollars, as TENAX THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$48,500$0$395,200$0$443,700

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TENAX THERAPEUTICS, INC. DEF 14A filed April 22, 2026, accession 0001193125-26-168580, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

TENAX THERAPEUTICS pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance

The rest of the TENAX THERAPEUTICS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Christopher T. GiordanoDirector$0
Gerald T. ProehlChair of the Board—
June AlmenoffIndependent Director$454,700
Michael DavidsonIndependent Director$452,700
Robyn M. HunterIndependent Director$460,200
Stuart RichDirector$0

The full TENAX THERAPEUTICS compensation record

free company brief

This page is one director within TENAX THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy